The role of HGF/MET in liver cancer

Future Med Chem. 2021 Nov;13(21):1829-1832. doi: 10.4155/fmc-2021-0128. Epub 2021 Sep 27.
No abstract available

Keywords: epigenetic changes; hepatocellular carcinoma; hepatocyte growth factor; mesenchymal–epithelial transition; tumor suppressor gene; tyrosine kinase inhibitors.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Crizotinib / pharmacology
  • Hepatocyte Growth Factor / antagonists & inhibitors
  • Hepatocyte Growth Factor / genetics
  • Hepatocyte Growth Factor / metabolism*
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors
  • Proto-Oncogene Proteins c-met / genetics
  • Proto-Oncogene Proteins c-met / metabolism*

Substances

  • Antineoplastic Agents
  • Crizotinib
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met